Low alpha-synuclein levels in the blood are associated with insulin resistance

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Rodriguez Araujo, Gerardo ^a   Nakagami, Hironori ^a   Takami, Yoichi ^a   Katsuya, Tomohiro ^b   Akasaka, Hiroshi ^c   Saitoh, Shigeyuki ^c   Shimamoto, Kazuaki ^c   Morishita, Ryuichi ^b   Rakugi, Hiromi ^a   Kaneda, Yasufumi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c SAPPORO MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; FAT INTAKE; GLUCOSE; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ADIPOSE TISSUE; ANIMAL; BLOOD; BODY MASS; CROSS-SECTIONAL STUDY; FAT INTAKE; HUMAN; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIPID DIET; METABOLISM; MOUSE; PHYSIOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ADIPOSE TISSUE; ALPHA-SYNUCLEIN; ANIMALS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIET, HIGH-FAT; DIETARY FATS; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84937019580     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12081     Document Type: Article

References (34)

1. Malik, S. et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 110, 1245-1250 (2004).
2. Burton, W. N., Chen, C. Y., Li, X., Schultz, A. B. & Abrahamsson, H. The association of self-reported employee physical activity with metabolic syndrome, health care costs, absenteeism, and presenteeism. Journal of occupational and environmental medicine/American College of Occupational and Environmental Medicine. 56, 919-926 (2014).
3. Lebovitz, H. E. Insulin resistance: definition and consequences. Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association. 109, S135-148 (2001).
4. Lusis, A. J., Attie, A. D. & Reue, K. Metabolic syndrome: from epidemiology to systems biology. Nature reviews Genetics. 9, 819-830 (2008).
5. Rachek, L. I., Musiyenko, S. I., LeDoux, S. P. & Wilson, G. L. Palmitate induced mitochondrial deoxyribonucleic acid damage and apoptosis in l6 rat skeletal muscle cells. Endocrinology. 148, 293-299 (2007).
6. Shi, H. et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. The Journal of clinical investigation. 116, 3015-3025 (2006).
7. Falcone, C. et al. Relationship between sRAGE and eotaxin-3 with CRP in hypertensive patients at high cardiovascular risk. Journal of nephrology. 26, 144-151 (2013).
8. Lee, H. K. et al. Mitochondrial dysfunction and metabolic syndrome-looking for environmental factors. Biochimica et biophysica acta. 1800, 282-289 (2010).
9. Nagasumi, K. et al. Overexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice. Diabetes. 58, 1067-1076 (2009).
10. Goedert, M. Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci. 2, 492-501 (2001).
11. Duran, R. et al. Plasma alpha-synuclein in patients with Parkinson's disease with and without treatment. Mov Disord. 25, 489-493 (2010).
12. Barbour, R. et al. Red blood cells are the major source of alpha-synuclein in blood. Neurodegener Dis. 5, 55-59 (2008).
13. Park, S. M. et al. Evidence that alpha-synuclein functions as a negative regulator of Ca(++)-dependent alpha-granule release from human platelets. Blood. 100, 2506-2514 (2002).
14. Hong, S., Lee, H. K., Kim, C. Y. & Seong, G. J. Identification and localization of alpha-synuclein in human cornea. Korean J Ophthalmol. 22, 145-146 (2008).
15. Mollenhauer, B. & Trenkwalder, C. Neurochemical biomarkers in the differential diagnosis of movement disorders. Mov Disord. 24, 1411-1426 (2009).
16. Golovko, M. Y., et al. Alpha-synuclein gene deletion decreases brain palmitate uptake and alters the palmitate metabolism in the absence of alpha-synuclein palmitate binding. Biochemistry. 44, 8251-8259 (2005).
17. Kurz, A., et al. Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress. Cell Mol Life Sci. 68, 721-733 (2011).
18. Geng, X., et al. alpha-Synuclein binds the K(ATP) channel at insulin-secretory granules and inhibits insulin secretion. American journal of physiology Endocrinology and metabolism. 300, E276-286 (2011).
19. Rodriguez-Araujo, G. et al. Alpha-synuclein elicits glucose uptake and utilization in adipocytes through the Gab1/PI3K/Akt transduction pathway. Cell Mol Life Sci. 70, 1123-1133 (2013).
20. Cabin, D. E., et al. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci. 22, 8797-8807 (2002).
21. Wallace, T. M., Levy, J. C. & Matthews, D. R. Use and abuse of HOMA modeling. Diabetes Care. 27, 1487-1495 (2004).
22. Herbach, N. et al. Dominant-negative effects of a novel mutated Ins2 allele causes early-onset diabetes and severe beta-cell loss in Munich Ins2C95S mutant mice. Diabetes. 56, 1268-1276 (2007).
23. Mather, K. Surrogate measures of insulin resistance: of rats, mice, and men. Am J Physiol Endocrinol Metab. 296, E398-399 (2009).
24. Stolarczyk, E. et al. Improved insulin sensitivity despite increased visceral adiposity in mice deficient for the immune cell transcription factor T-bet. Cell metabolism. 17, 520-533 (2013).
25. Saltiel, A. R. & Kahn, C. R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 414, 799-806 (2001).
26. Taniguchi, C. M., Emanuelli, B. & Kahn, C. R. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol. 7, 85-96 (2006).
27. Turner, N., Cooney, G. J., Kraegen, E. W. & Bruce, C. R. Fatty acid metabolism, energy expenditure and insulin resistance in muscle. J Endocrinol. 220, T61-79 (2014).
28. Haque, F., Pandey, A. P., Cambrea, L. R., Rochet, J. C. & Hovis, J. S. Adsorption of alpha-synuclein on lipid bilayers: modulating the structure and stability of protein assemblies. J Phys Chem B. 114, 4070-4081 (2010).
29. Gurnev, P.A. et al. Alpha-synuclein lipid-dependent membrane binding and translocation through the alpha-hemolysin channel. Biophys J. 106, 556-565 (2014).
30. Furugen, M. et al. Matsuda-DeFronzo insulin sensitivity index is a better predictor than HOMA-IR of hypertension in Japanese: the Tanno-Sobetsu study. Journal of human hypertension. 26, 325-333 (2012).
31. Obara, F., Saitoh, S., Takagi, S. & Shimamoto, K. Influence of hypertension on the incidence of cardiovascular disease in two rural communities in Japan: the Tanno-Sobetsu [corrected] study. Hypertension research : official journal of the Japanese Society of Hypertension. 30, 677-682 (2007).
32. Winzell, M. S. & Ahren, B. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes. 53, S215-219 (2004).
33. Shiuchi, T. et al. Hypothalamic orexin stimulates feeding-associated glucose utilization in skeletal muscle via sympathetic nervous system. Cell Metab. 10, 466-480 (2009).
34. Ayala, J. E. et al. Hyperinsulinemic-euglycemic clamps in conscious, unrestrained mice. J Vis Exp 57, 3188 (2011).